Gastritis OLGA-staging & gastric cancer risk: a twelve year clinico-pathological follow-up study - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Alimentary Pharmacology and Therapeutics Année : 2010

Gastritis OLGA-staging & gastric cancer risk: a twelve year clinico-pathological follow-up study

Michele de Boni
  • Fonction : Auteur
  • PersonId : 886877
Manuela de Bona
  • Fonction : Auteur
  • PersonId : 886879
Luciano Giacomelli
  • Fonction : Auteur
  • PersonId : 886880
Matteo Fassan
  • Fonction : Auteur
  • PersonId : 886881
Daniela Basso
  • Fonction : Auteur
  • PersonId : 886882
Mario Plebani
  • Fonction : Auteur
  • PersonId : 886883
David y Graham
  • Fonction : Auteur
  • PersonId : 886884

Résumé

Background: Intestinal-type gastric cancer (GC) still ranks among the high-incidence, highly lethal malignancies. Atrophic gastritis is the cancerization field in which GC develops. The current histological reporting formats for gastritis do not include any (atrophy-based) ranking of GC risk. Aim: This clinico-pathological long-term follow-up study tested the gastritis OLGA-staging in prognosticating neoplastic progression. Methods: Ninety-three Italian patients were followed up for more than 12 years (range=144-204 months). Clinical examinations, pepsinogen serology, endoscopy and histology (also assessing H. pylori status) were done both at enrolment (T1) and at the end of the follow-up (T2). Results: All invasive or intra-epithelial gastric neoplasia were consistently associated with high-risk (III/IV) OLGA stages. There was a significant inverse correlation between the mean pepsinogen ratio and the OLGA stage (test for trend; p<0.001). OLGA staging at T1 predicted both the OLGA stage (Kaplan Maier log rank test, p=0.001) and the neoplasia at T2 (Kaplan Maier log rank test, p=0.001). Conclusions: This long-term follow-up study provides the first evidence that gastritis OLGA-staging conveys relevant information on the clinico-pathological outcome of gastritis and, therefore, for patient management. According to OLGA-staging and H. pylori-status, gastritis patients could be confidently stratified and managed according to their different cancer risk.

Mots clés

Fichier principal
Vignette du fichier
PEER_stage2_10.1111%2Fj.1365-2036.2010.04277.x.pdf (452.79 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-00552536 , version 1 (06-01-2011)

Identifiants

Citer

Massimo Rugge, Michele de Boni, Gianmaria Pennelli, Manuela de Bona, Luciano Giacomelli, et al.. Gastritis OLGA-staging & gastric cancer risk: a twelve year clinico-pathological follow-up study. Alimentary Pharmacology and Therapeutics, 2010, ⟨10.1111/j.1365-2036.2010.04277.x⟩. ⟨hal-00552536⟩

Collections

PEER
73 Consultations
248 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More